Pages that link to "Q48712757"

The following pages link to Intratumoral infusion of the monoclonal antibody, mAb 425, against the epidermal-growth-factor receptor in patients with advanced malignant glioma (Q48712757):

Displaying 37 items.

• Targeted molecular therapies against epidermal growth factor receptor: past experiences and challenges (Q26862516) (← links)
• Current Understanding on EGFR and Wnt/β-Catenin Signaling in Glioma and Their Possible Crosstalk (Q26865911) (← links)
• Convection-enhanced delivery of targeted toxins for malignant glioma (Q31038118) (← links)
• The epidermal growth factor receptor and its inhibition in cancer therapy (Q33716127) (← links)
• Strategies to adapt adenoviral vectors for targeted delivery (Q33833388) (← links)
• Agile delivery of protein therapeutics to CNS (Q34079647) (← links)
• Mitogenic signaling and the relationship to cell cycle regulation in astrocytomas. (Q34283477) (← links)
• An update on epidermal growth factor receptor inhibitors (Q34457436) (← links)
• Local treatment of brain tumors with targeted chimera cytotoxic proteins (Q34798727) (← links)
• Overview of the clinical efficacy of investigational anticancer drugs (Q35067125) (← links)
• Immunotoxin therapy for CNS tumor (Q35210454) (← links)
• Convection-enhanced drug delivery of interleukin-4 Pseudomonas exotoxin (PRX321): increased distribution and magnetic resonance monitoring (Q35453991) (← links)
• Radioimmunotargeting of malignant glioma by monoclonal antibody D2C7 reactive against both wild-type and variant III mutant epidermal growth factor receptors (Q35659088) (← links)
• Monoclonal antibodies for brain tumour treatment (Q35873775) (← links)
• Immunotherapy for malignant gliomas: emphasis on strategies of active specific immunotherapy using autologous dendritic cells (Q35903574) (← links)
• Perspectives of cellular and molecular neurosurgery (Q36021591) (← links)
• Emerging monoclonal antibody therapies for malignant gliomas (Q36764016) (← links)
• Convection-enhanced delivery for the treatment of brain tumors (Q36854365) (← links)
• Immunotherapeutic treatment strategies for primary brain tumors (Q37117689) (← links)
• Recent advances of dendritic cells (DCs)-based immunotherapy for malignant gliomas (Q37517954) (← links)
• Targeted drug delivery for treatment and imaging of glioblastoma multiforme (Q37523966) (← links)
• Cell Surface Receptors in Malignant Glioma (Q37869308) (← links)
• Targeting the epidermal growth factor receptor in solid tumor malignancies. (Q37990044) (← links)
• Convection-enhanced delivery for the treatment of glioblastoma (Q38368962) (← links)
• Convection-enhanced Delivery of Therapeutics for Malignant Gliomas (Q38782309) (← links)
• Recent progress in protein-protein interaction study for EGFR-targeted therapeutics (Q38899428) (← links)
• Surgical Considerations in the Optimal Management of Patients with Malignant Brain Tumors. (Q39417263) (← links)
• Induction of a T- and B-cell response against a unique amino acid sequence of the mouse IgG2A hinge region in a MAb-treated patient (Q40644388) (← links)
• Induction of apoptosis and activation of the caspase cascade by anti-EGF receptor monoclonal antibodies in DiFi human colon cancer cells do not involve the c-jun N-terminal kinase activity (Q41887619) (← links)
• Convection-enhanced drug delivery for gliomas (Q43159976) (← links)
• Interleukin-13 receptor as a unique target for anti-glioblastoma therapy (Q43567315) (← links)
• Intratumoral immunotoxin treatment of human malignant brain tumors in immunodeficient animals (Q45714399) (← links)
• Novel anti–brain tumor cytotoxins specific for cancer cells (Q48466719) (← links)
• A dimeric bispecific miniantibody combines two specificities with avidity (Q57840051) (← links)
• Intracisternal delivery of PEG-coated gold nanoparticles results in high brain penetrance and long-lasting stability (Q64080765) (← links)
• Advances in Glioblastoma Operative Techniques (Q90508527) (← links)
• Convection-Enhanced Delivery in Malignant Gliomas: A Review of Toxicity and Efficacy (Q92712819) (← links)